Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds EF Hutton Reiterates Buy on Jasper Therapeutics, Maintains $6.85 Price Target

EF Hutton Reiterates Buy on Jasper Therapeutics, Maintains $6.85 Price Target

EF Hutton analyst Michael King reiterates Jasper Therapeutics (NASDAQ:JSPR) with a Buy and maintains $6.85 price target.

byBenzinga Newsdesk

February 27, 2023

1 minute read

EF Hutton analyst Michael King reiterates Jasper Therapeutics (NASDAQ:JSPR) with a Buy and maintains $6.85 price target.

Soaring Component Costs For iPhone 15 Could Signal A Price Hike For iPhone 16

By Benzinga Neuro

October 23, 8:33 AM

There's been a three-fold increase in the price of the 5x telephoto camera in comparison to the 3x module.

AAPL

P/E Ratio Insights for AutoZone

By Benzinga Insights

August 17, 3:15 PM

In the current market session, AutoZone Inc. (NYSE:AZO) stock price is at $2467.11, after a 0.90% drop. However,…

AZO

Rivian Loses Another Top Executive: Chief Lobby Officer To Depart In February

By Shanthi Rexaline

January 24, 3:38 AM

Rivian Automotive Inc’s (NASDAQ: RIVN) chief lobby officer Jim Chen is exiting the electric vehicle maker, joining a slew of C-suite talen

MBGAF

$100 Invested In Energy Fuels 5 Years Ago Would Be Worth This Much Today

By Benzinga Insights

September 1, 5:39 PM

Energy Fuels (AMEX:UUUU) has outperformed the market over the past 5 years by 22.57% on an annualized basis producing an average annual return of 32.58%. Currently, Energy Fuels has a market capitalization of $1.14 billion.

UUUU

EF Hutton Reiterates Buy on Jasper Therapeutics, Maintains $6.85 Price Target

Related Posts

Soaring Component Costs For iPhone 15 Could Signal A Price Hike For iPhone 16

P/E Ratio Insights for AutoZone

Rivian Loses Another Top Executive: Chief Lobby Officer To Depart In February

$100 Invested In Energy Fuels 5 Years Ago Would Be Worth This Much Today